Resveratrol-induced limitation of dysfunction of mitochondria isolated from rat brain in an anoxia-reoxygenation model

Life Sciences

Volumn 71, Issue 26, 2002, Pages 3091-3108

  Zini, Roland ^a   Morin, Christophe ^a   Bertelli, Aldo ^b   Bertelli, Alberto A E ^b   Tillement, Jean Paul ^a  

^a FACULTÉ DE MÉDECINE   (France)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Anoxia reoxygenation; Apoptosis; Brain; Mitochondria; Reactive oxygen species; Resveratrol; Uncoupling

Indexed keywords

CYTOCHROME C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; SUPEROXIDE;

ANIMAL CELL; ARTICLE; BRAIN HYPOXIA; BRAIN MITOCHONDRION; BRAIN OXYGEN CONSUMPTION; BRAIN PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; ENZYME RELEASE; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT; REOXYGENATION; RESPIRATION CONTROL;

ANIMALS; BRAIN; CELL HYPOXIA; MITOCHONDRIA; OXYGEN; PHOSPHORYLATION; RATS; REACTIVE OXYGEN SPECIES;

EID: 0037111102     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02161-6     Document Type: Article

References (50)

1. Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as a biological fluid: history, production, and role in disease prevention. Journal of Clinical and Laboratory Analysis. 11:1997;287-313.
2. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sciences. 61:1997;2103-2110.
3. Tadolini B., Juliano C., Piu L., Franconi F., Cabrini L. Resveratrol inhibition of lipid peroxidation. Free Radical Research. 33:2000;105-114.
4. Pace-Asciak C.R., Hanh S., Diamandis E.P., Soleas G., Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clinica et Chimica Acta. 235:1995;207-219.
5. Moreno J.J. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. Journal of Pharmacology and Experimental Therapeutics. 294:2000;333-338.
6. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochemical Pharmacology. 59:2000;865-870.
7. Bertelli A.A.E., Giovannini L., de Caterina R. Antiplatelet activity of cis-resveratrol. Drugs under Experimental and Clinical Research. XXII:1996;61-63.
8. Ray P.S., Maulik G., Cordis G.A., Bertelli A.A., Bertelli A., Das D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biology and Medicine. 27:1999;160-169.
9. Sato M., Ray P.S., Maulik G., Maulik N., Engelman R.M., Bertelli A.A., Bertelli A., Das D.K. Myocardial protection with red wine extract. Journal of Cardiovascular Pharmacology. 35:2000;263-268.
10. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
11. Damianaki A., Bakogeorgou E., Kampa M., Notas G., Hatzoglou A., Panagiotou S., Gemetzi C., Kouroumalis E., Martin E., Castanas E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. Journal of Cellular Biochemistry. 78:2000;429-441.
12. Stewart J.R., Ward N.E., Ioannides C.G., O'brian C.A. Resveratrol preferentially inhibits protein kinase c-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry. 38:1999;13244-13251.
13. Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 92:1998;996-1002.
14. Pervaiz S. Resveratrol - From the bottle to the bedside? Leukemia and Lymphoma. 40:2001;491-498.
15. Tsan M.F., White J.E., Maheshwari J.G., Bremner T.A., Sacco J. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. British Journal of Haematology. 109:2000;405-412.
16. Wieder T., Prokop A., Bagci B., Essmann F., Bernicke D., Schulze-Osthoff K., Dorken B., Schmalz H.G., Daniel P.T., Henze G. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia. 15:2001;1735-1742.
17. Dorrie J., Gerauer H., Wachter Y., Zunino S.J. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Research. 61:2001;4731-4739.
18. 1-ATPase/ATP synthase by polyphenolic phytochemicals. British Journal of Pharmacology. 130:2000;1115-1123.
19. Bertelli A.A.E., Giovannini L., Stradi R., Bertelli A., Tillement J.P. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. International Journal of Tissue Reaction. XVIII:1996;67-71.
20. Belguendouz L., Fremont L., Gozzelino M.T. Interaction of trans-resveratrol with plasma lipoproteins. Biochemical Pharmacology. 55:1998;811-816.
21. Lemasters J.J., Nieminen A.L. Mitochondrial oxygen radical formation during reductive and oxidative stress to intact hepatocytes. Bioscience Report. 17:1997;281-291.
22. Zini R., Morin C., Bertelli A., Bertelli A.A.E., Tillement J.P. Effects of resveratrol on the rat brain respiratory chain. Drugs under Experimental and Clinical Research. XXV:1999;87-97.
23. Virgili M., Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neuroscience Letter. 281:2000;123-126.
24. Du G., Willet K., Mouithys-Mickalad A., Sluse-Goffart M., Droy-Lefaix M.T., Sluse F.E. EGb 761 protects liver mitochondria against injury induced by in vitro anoxia/reoxygenation. Free Radical Biology and Medicine. 27:1999;596-604.
25. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
26. Susin S.A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochimica et Biophysica Acta. 1366:1998;151-165.
27. Zou H., Li Y., Liu X., Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. Journal of Biological Chemistry. 274:1999;11549-11556.
28. Mc Cord J.M., Turrens J.F. Mitochondrial injury by ischemia and reperfusion. Current on Topics and Bioenergetics. 17:1994;173-195.
29. Sims N.R. Rapid isolation of metabolically active mitochondria isolated from brain subregions using Percoll density gradient centrifugation. Journal of Neurochemistry. 55:1990;698-707.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 93:1951;265-275.
31. La Piana G., Fransvea E., Marzulli D., Lofrumento N.E. Mitochondrial membrane potential supported by exogenous cytochrome c oxidation mimics the early stages of apoptosis. Biochemical and Biophysical Research Communications. 246:1998;556-561.
32. Cormier A., Morin C., Zini R., Tillement J.P., Lagrue G. In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Research. 900:2001;72-79.
33. Mc Cord J.M., Fridovitch I. Superoxide dismutase: an enzymic function for erythrocuprein. Journal of Biological Chemistry. 244:1969;6049-6055.
34. Mecocci P., Beal M.F., Cecchetti R., Polidori M.C., Cherubini A., Chionne F., Avellini L., Romano G., Senin U. Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Molecular and Chemical Neuropathology. 31:1997;53-64.
35. Ricchelli F., Gobbo S., Moreno G., Salet C. Changes of fluidity of mitochondrial membranes induced by the permeability transition. Biochemistry. 38:1999;9295-9300.
36. Urien S. Micropharm-K, microcomputer interactive program for the analysis and the simulation of pharmacokinetic processes. Pharmaceutical Research. 12:1995;1225-1230.
37. Ruuge E.K., Ledenev A.N., Lakomkin V.L., Konstantinov A.A., Ksenzenko M.Y. Free radical metabolites in myocardium during ischemia and reperfusion. American Journal of Physiology. 261:1991;81-86.
38. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proceedings of National Academy of Sciences USA. 87:1990;5144-5147.
39. 2 for maximum cytochrome turnover in red muscle in situ. American Journal of Physiology. 252:1987;H906-H915.
40. Piantadosi C.A., Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke. 27:1996;327-332.
41. Kristian T., Siesjo B.K. Calcium-related damage in ischemia. Life Sciences. 59:1996;357-367.
42. Szöllosi J. Damjanovich S., Edidin M., Tron L., Szöllosi J. Mobility and Proximity in Biological Membranes. 1994;137-208 CRC Press, Boca Raton.
43. Lesnefsky E.J., Moghaddas S., Tandler B., Kerner J., Hoppel C.L. Mitochondrial dysfunction in cardiac disease: Ischemia-reperfusion, aging, and heart failure. Journal of Molecular and Cellular Cardiology. 33:2001;1065-1089.
44. Perez-Pinzon M.A., Xu G.P., Born J., Lorenzo J., Busto R., Rosenthal M., Sick T.J. Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia. Journal of Cerebral Blood Flow and Metabolism. 19:1999;39-43.
45. Shidoji Y., Hyaashi K., Komura S., Ohishi N., Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochemical and Biophysical Research Communications. 264:1999;343-347.
46. Hayakawa M., Ogawa T., Sugiyama S., Ozawa T. Hydroxyl radical and leucotoxin biosynthesis in neutrophil plasma membrane. Biochemical and Biophysical Research Communications. 161:1989;1077-1085.
47. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
48. Steffanelli C., Bonavita F., Stanic I., Farruggia G., Falcieri E., Robuffo I., Pignatti C., Muscari C., Rossoni C., Guarnieri C., Calderera M. ATP depletion inhibits glucorticoid-induced thymocyte apoptosis. Biochemical Journal. 322:1997;909-917.
49. Rossignol R., Letellier T., Malgat M., Rocher C., Mazat J.P. Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases. Biochemical Journal. 347:2000;45-53.
50. Skulachev V.P. Uncoupling: new approaches to an old problem of bioenergetics. Biochimica et Biophysica Acta. 1363:1998;100-124.